Allopurinol-Induced Severe Cutaneous Adverse Drug Reactions: An Analysis of Spontaneous Reports in Malaysia (2000–2018)
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Allopurinol-Induced Severe Cutaneous Adverse Drug Reactions: An Analysis of Spontaneous Reports in Malaysia (2000–2018)
Authors
Keywords
-
Journal
Therapeutic Innovation & Regulatory Science
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-04
DOI
10.1007/s43441-020-00245-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2020 American College of Rheumatology Guideline for the Management of Gout
- (2020) John D. FitzGerald et al. ARTHRITIS CARE & RESEARCH
- Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease
- (2018) Juan Jesus Carrero et al. Nature Reviews Nephrology
- Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea
- (2018) Min-Suk Yang et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Genetic markers of severe cutaneous adverse reactions
- (2018) Jae-Woo Jung et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population
- (2017) Niwat Saksit et al. Pharmacogenetics and Genomics
- How to prevent allopurinol hypersensitivity reactions?
- (2017) Lisa K. Stamp et al. RHEUMATOLOGY
- The British Society for Rheumatology Guideline for the Management of Gout
- (2017) Michelle Hui et al. RHEUMATOLOGY
- An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing
- (2015) Jae-Woo Jung et al. GENETICS IN MEDICINE
- Allopurinol Use and Risk of Fatal Hypersensitivity Reactions
- (2015) Chien-Yi Yang et al. JAMA Internal Medicine
- Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin
- (2014) Wen-Hung Chung et al. ANNALS OF THE RHEUMATIC DISEASES
- Recurrence and Mortality Following Severe Cutaneous Adverse Reactions
- (2014) Yaron Finkelstein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
- (2014) Surasak Saokaew et al. PLoS One
- Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response
- (2013) J. Yun et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Human Leukocyte Antigen-B Genotype and Allopurinol Dosing
- (2012) M S Hershfield et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Severe Cutaneous Reactions Requiring Hospitalization in Allopurinol Initiators: A Population-Based Cohort Study
- (2012) Seoyoung C. Kim et al. ARTHRITIS CARE & RESEARCH
- Patient Experiences of Serious Adverse Drug Reactions and Their Attitudes to Medicines
- (2011) Tehreem F. Butt et al. DRUG SAFETY
- Adverse drug reactions (ADRs) associated with hospital admissions – elderly female patients are at highest risk
- (2011) C. Hofer-Dueckelmann et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands
- (2010) Eline M. Rodenburg et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Epidemiology and risk factors for drug allergy
- (2010) Bernard Y-H. Thong et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now